Recombinant MERS-CoV antibody (RBD)
MERS-CoV
Reactivity: Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
Neut, SPR, FACS
Host: Human
Monoclonal
4V2
unconjugated
Recombinant Antibody
-
- Target See all MERS-CoV Antibodies
- MERS-CoV (MERS-Coronavirus (MERS-CoV))
- Antibody Type
- Recombinant Antibody
- Binding Specificity
- RBD
- Reactivity
- Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
-
Host
-
Human
- Expression System
- Mammalian cells
-
Clonality
- Monoclonal
-
Conjugate
- This MERS-CoV antibody is un-conjugated
-
Application
- Neutralization (Neut), Surface Plasmon Resonance (SPR), Flow Cytometry (FACS)
- Purpose
- Recombinant Anti-MERS-CoV RBD Antibody (4V2)
- Purification
- Protein A or G purified from cell culture supernatant.
- Purity
- >95 % by SDS-PAGE.
- Clone
- 4V2
- Isotype
- IgG1
- Top Product
- Discover our top product MERS-CoV Primary Antibody
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 mg/mL
- Buffer
- 0.01M PBS, pH 7.4.
- Storage
- -20 °C,-80 °C
- Storage Comment
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at +4°C short term (1-2 weeks). Store at -20 °C 12 months. Store at -80°C long term.
-
- Target
- MERS-CoV (MERS-Coronavirus (MERS-CoV))
- Alternative Name
- MERS-Coronavirus (MERS-CoV Products)
- Background
- Spike glycoprotein, S glycoprotein, E2, Peplomer protein, RBD, Spike protein S1, S, Receptor-Binding Domain, SARS-like Coronaviruses
-
You are here:
